O Shaughnessy Asset Management LLC boosted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 55.4% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,986 shares of the biotechnology company’s stock after purchasing an additional 708 shares during the quarter. O Shaughnessy Asset Management LLC’s holdings in Axon Enterprise were worth $621,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in AXON. Norges Bank acquired a new position in Axon Enterprise during the 4th quarter valued at approximately $195,406,000. Motley Fool Asset Management LLC boosted its position in Axon Enterprise by 238.7% during the 1st quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company’s stock valued at $153,981,000 after purchasing an additional 346,838 shares during the period. Vanguard Group Inc. boosted its position in Axon Enterprise by 2.7% during the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock worth $2,547,878,000 after acquiring an additional 212,401 shares during the period. International Assets Investment Management LLC acquired a new position in Axon Enterprise during the 4th quarter worth $39,907,000. Finally, Goldman Sachs Group Inc. boosted its position in Axon Enterprise by 110.0% during the 4th quarter. Goldman Sachs Group Inc. now owns 276,011 shares of the biotechnology company’s stock worth $71,302,000 after acquiring an additional 144,568 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.
Insider Activity at Axon Enterprise
In related news, Director Julie A. Cullivan sold 993 shares of the company’s stock in a transaction on Friday, May 31st. The stock was sold at an average price of $281.72, for a total transaction of $279,747.96. Following the transaction, the director now directly owns 4,553 shares of the company’s stock, valued at $1,282,671.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, Director Julie A. Cullivan sold 993 shares of the company’s stock in a transaction on Friday, May 31st. The stock was sold at an average price of $281.72, for a total transaction of $279,747.96. Following the transaction, the director now directly owns 4,553 shares of the company’s stock, valued at $1,282,671.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jeri Williams sold 308 shares of the business’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $310.07, for a total value of $95,501.56. Following the completion of the transaction, the director now owns 1,607 shares in the company, valued at approximately $498,282.49. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 89,447 shares of company stock valued at $27,684,677. Company insiders own 6.10% of the company’s stock.
Axon Enterprise Stock Down 0.1 %
Shares of Axon Enterprise stock opened at $310.59 on Monday. The stock’s fifty day moving average is $294.49 and its 200-day moving average is $292.33. The firm has a market capitalization of $23.44 billion, a PE ratio of 90.82, a price-to-earnings-growth ratio of 7.00 and a beta of 0.95. The company has a quick ratio of 2.55, a current ratio of 2.91 and a debt-to-equity ratio of 0.37. Axon Enterprise, Inc. has a 12-month low of $175.37 and a 12-month high of $329.87.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its earnings results on Friday, May 10th. The biotechnology company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.95 by $0.20. The company had revenue of $460.74 million for the quarter, compared to analyst estimates of $441.57 million. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. Axon Enterprise’s revenue for the quarter was up 34.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.51 earnings per share. Equities analysts anticipate that Axon Enterprise, Inc. will post 2.35 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of research analysts have issued reports on AXON shares. William Blair reiterated an “outperform” rating on shares of Axon Enterprise in a research report on Wednesday, April 24th. JPMorgan Chase & Co. boosted their price target on Axon Enterprise from $330.00 to $365.00 and gave the stock an “overweight” rating in a research report on Thursday, April 11th. JMP Securities reiterated a “market outperform” rating and set a $375.00 price target on shares of Axon Enterprise in a research report on Tuesday, May 7th. Jefferies Financial Group assumed coverage on Axon Enterprise in a research report on Wednesday, July 17th. They set a “buy” rating and a $385.00 price target for the company. Finally, Morgan Stanley upped their price objective on Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, April 26th. Two investment analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $342.54.
View Our Latest Report on AXON
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Axon Enterprise and related companies with MarketBeat.com’s FREE daily email newsletter.
